Apriem Advisors - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Apriem Advisors ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2016$19,000
+11.8%
3,1500.0%0.01%
+20.0%
Q3 2016$17,000
+41.7%
3,1500.0%0.01%
+25.0%
Q2 2016$12,000
+9.1%
3,150
-24.1%
0.00%0.0%
Q1 2016$11,000
+1000.0%
4,150
+1297.3%
0.00%
Q3 2013$1,0002970.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2016
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 477,621$1,065,0001.44%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,804$3,358,0001.18%
Nantahala Capital Management 7,000,000$15,610,0000.69%
Hikari Power Ltd 1,900,000$4,237,0000.50%
Trellus Management Company, LLC 112,500$251,0000.34%
Cheyne Capital Management (UK) LLP 206,500$462,0000.20%
KNOTT DAVID M 201,400$449,0000.18%
Paulson & Co. 4,000,000$8,920,0000.17%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,041,695$2,323,0000.15%
Clear Harbor Asset Management, LLC 318,460$710,0000.13%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders